Biltmore Family Office’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Hold
8,704
0.21% 79
2025
Q4
$1.47M Sell
8,704
-124
-1% -$20.1K 0.2% 80
2025
Q3
$1.27M Hold
8,828
0.18% 84
2025
Q2
$1.12M Hold
8,828
0.19% 81
2025
Q1
$1.13M Hold
8,828
0.19% 81
2024
Q4
$1.17M Sell
8,828
-212
-2% -$29.8K 0.2% 78
2024
Q3
$1.32M Sell
9,040
-125
-1% -$18.1K 0.23% 77
2024
Q2
$1.26M Hold
9,165
0.23% 70
2024
Q1
$1.26M Sell
9,165
-867
-9% -$118K 0.25% 69
2023
Q4
$1.36M Buy
10,032
+9,507
+1,811% +$1.16M 0.28% 61
2023
Q3
$64.3K Hold
525
0.01% 196
2023
Q2
$66.7K Hold
525
0.01% 191
2023
Q1
$67.8K Hold
525
0.01% 232
2022
Q4
$68.9K Hold
525
0.01% 221
2022
Q3
$61K Hold
525
0.01% 176
2022
Q2
$62K Hold
525
0.02% 176
2022
Q1
$68K Hold
525
0.01% 184
2021
Q4
$80K Hold
525
0.02% 199
2021
Q3
$85K Hold
525
0.02% 177
2021
Q2
$86K Hold
525
0.02% 163
2021
Q1
$79K Hold
525
0.02% 156
2020
Q4
$80K Hold
525
0.02% 157
2020
Q3
$71K Hold
525
0.04% 140
2020
Q2
$72K Hold
525
0.04% 150
2020
Q1
$57K Sell
525
-150
-22% -$17.3K 0.04% 145
2019
Q4
$81K Sell
675
-750
-53% -$83.7K 0.03% 172
2019
Q3
$142K Hold
1,425
0.06% 147
2019
Q2
$155K Buy
+1,425
New +$152K 0.08% 135

Other funds holding IBB

Biltmore Family Office's IBB Position: Q1 2026 in Review

Biltmore Family Office held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 8,704 shares worth $1.47M. The position accounts for 0.21% of the portfolio, ranked #79.

Biltmore Family Office first reported a position in IBB in Q2 2019 and has held it in 28 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Biltmore Family Office held 8,704 shares of iShares Biotechnology ETF worth $1.47M as of Q1 2026.
  • Biltmore Family Office left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.21% of Biltmore Family Office's portfolio in Q1 2026, its #79 holding.
  • Biltmore Family Office first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 28 quarters since.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Biltmore Family Office's 13F filing for Q1 2026, filed 11 May 2026.